University of Tehran-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2024

  1. Nanoliposomes as nonviral vectors in cancer gene therapy

    MedComm, Vol. 5, Núm. 7

2023

  1. Chitosan-based nanoscale systems for doxorubicin delivery: Exploring biomedical application in cancer therapy

    Bioengineering and Translational Medicine, Vol. 8, Núm. 1

  2. Rhabdomyosarcoma: Current Therapy, Challenges, and Future Approaches to Treatment Strategies

    Cancers, Vol. 15, Núm. 21

2022

  1. Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects

    Drug Discovery Today, Vol. 27, Núm. 2, pp. 436-455

  2. Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: stimuli-responsive carriers, co-delivery and suppressing resistance

    Expert Opinion on Drug Delivery, Vol. 19, Núm. 4, pp. 355-382

  3. Nanotechnological Approaches in Prostate Cancer Therapy: Integration of engineering and biology

    Nano Today, Vol. 45

2021

  1. AIE-featured tetraphenylethylene nanoarchitectures in biomedical application: Bioimaging, drug delivery and disease treatment

    Coordination Chemistry Reviews, Vol. 447

  2. Hyaluronic acid-based nanoplatforms for Doxorubicin: A review of stimuli-responsive carriers, co-delivery and resistance suppression

    Carbohydrate Polymers, Vol. 272

2020

  1. Induced cell migration based on a bioactive hydrogel sheet combined with a perfused microfluidic system

    Biomedical Materials (Bristol), Vol. 15, Núm. 4